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Edited by Irmgard SinningAbstract The polyamine synthesis enzyme spermidine synthase
(SPDS) has been cloned from themodel nematodeCaenorhabditis
elegans. Biochemical characterisation of the recombinantly ex-
pressed protein revealed a high degree of similarity to other
eukaryotic SPDS with the exception of a low aﬃnity towards
the substrate decarboxylated S-adenosylmethionine (Km =
110 lM) and a less pronounced feedback inhibition by the second
reaction product 5-methylthioadenosine (IC50 = 430 lM).TheC.
elegans protein that carries a nematode-speciﬁc insertion of 27
amino acids close to its N-terminus was crystallized, leading to
the ﬁrst X-ray structure of a dimeric eukaryotic SPDS.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The ubiquitously distributed polyamines spermidine and
spermine are aliphatic polycations that are involved in numer-
ous cellular functions. Changes of intracellular polyamine con-
centrations were shown to correlate with growth and
diﬀerentiation processes of pro- and eukaryotes. In polyamine
synthesis, spermidine synthase (SPDS, putrescine aminopropyl-
transferase) catalyses the transfer of an aminopropyl moiety of
decarboxylated S-adenosylmethionine (dcAdoMet) to putres-
cine, resulting in the formation of spermidine and 5 0-methylthi-
oadenosine (MTA). The precursor molecules putrescine and
dcAdoMet are provided by the two key enzymes of the pathway,
ornithine decarboxylase (ODC) and S-adenosylmethionine
decarboxylase (AdoMetDC). Some eukaryotes possess a second
aminopropyltransferase, spermine synthase (spermidine amino-
propyltransferase), and consequently contain spermine [1–3].
SPDS have been characterised from many sources [1,2] and
only recently, the ﬁrst crystal structure of an aminopropyltrans-Abbreviations: AdoDATO, S-adenosyl-1,8-diamino-3-thiooctane;
AdoMetDC, S-adenosylmethinone decarboxylase; AdoMet, S-adeno-
sylmethionine; dcAdoMet, decarboxylated S-adenosylmethionine;
DTT, dithiothreitol; 4-MCHA, trans-4-methylcyclohexylamine; MTA,
50-methylthioadenosine; ODC, ornithine decarboxylase; 30-RACE,
30-rapid ampliﬁcation of cDNA ends; SPDS, spermidine synthase
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doi:10.1016/j.febslet.2005.09.050ferase has been solved. The SPDSof the prokaryoteThermotoga
maritima was analysed in ligand-free state as well as complexed
with the substrate-product analogue S-adenosyl-1,8-diamino-3-
thiooctane (AdoDATO) [4]. In contrast to the dimeric SPDS of
eukaryotes, the T. maritima enzyme was found to have a tetra-
meric organisation. A monomer of T. maritima SPDS can be
subdivided into anN-terminal and aC-terminal domain, the lat-
ter exhibiting similarity to the topology found in numerous
nucleotide and dinucleotide-binding enzymes and in S-adeno-
sylmethionine-dependent methyltransferases. The binding site
of AdoDATO is formed by amino acid residues that are well
conserved among the known SPDS. Hence, a universal catalytic
mechanism for SPDSwas suggested. This was further conﬁrmed
by the X-ray structure of the human SPDS, solved by one of the
structure genomics consortia (PDB code 1ZDZ).
The polyamine synthesis pathway of the free-living nema-
tode Caenorhabditis elegans encompasses the enzymes ODC,
AdoMetDC and SPDS [5–8], whereas a homologous spermine
synthase gene is lacking. The three enzymes exhibit a tissue-
speciﬁc expression pattern in C. elegans suggesting that the
intestine represents the main place of polyamine production
[7]. C. elegans is a well established model organism to study
general biological processes like for example development.
Consistent with reports on other organisms [3,9], growth of
C. elegans depends on polyamines, since ODC null mutants
that do not have access to exogenous polyamines exhibit a
stage-speciﬁc block of embryogenesis [10].
Here, we report on the molecular cloning, recombinant
expression and biochemical characterisation of C. elegans
SPDS. Analysis of the crystal structure conﬁrmed a homodi-
meric organisation of the nematode enzyme and revealed a
high degree of conservation of the overall fold when compared
with the structure of the homotetrameric T. maritima SPDS.
Furthermore, a nematode-speciﬁc insertion that has been iden-
tiﬁed close to the N-terminus of the C. elegans and other nem-
atode SPDS was found to be located in close proximity to the
substrate binding site.2. Material and methods
2.1. Chemicals
Trans-4-methylcyclohexylamine (4-MCHA) and (S,R)-dcAdoMet
were generous gifts from Keijiro Samejima (Josai University, Sai-
tama, Japan). [1,4-14C]Putrescine dihydrochloride (107 mCi/mmol)
and [14C] spermidine trihydrochloride (112 mCi/mmol) were fromblished by Elsevier B.V. All rights reserved.
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amine were purchased from Sigma Aldrich (Mu¨nchen), spermidine
and putrescine from Fluka AG (Neu-Ulm).
2.2. C. elegans culture and nucleic acid preparation
The C. elegans strain Bristol N2 was cultured under standard condi-
tions at 22 C in the presence of E. coli strain OP50. Worms were sep-
arated from bacteria by sucrose ﬂotation [11]. Total RNA was
extracted by homogenising worms in the presence of TRIZOLe
according to the manufacturers instructions (Invitrogen).
2.3. Cloning of C. elegans SPDS
A putative C. elegans SPDS is annotated in the C. elegans genome
on chromosome II (gene Y46G5.19, EMBL Accession No.
AL110485). The corresponding open reading frame was ampliﬁed by
PCR using C. elegans cDNA or a C. elegans k-Zap cDNA library
(Stratagene) as template and gene-speciﬁc oligonucleotides based on
the identiﬁed genomic sequence CeSPDSExS: 5 0-GGATCCCAT-
GAACAAGCTGCACAAGGGA-3 0 and CeSPDSExAS: 5 0-
AAGCTTCTACTCCAAAGCATTTTTGAC-30 (introduced restric-
tion sites for BamHI and HindIII are underlined). PCR was performed
as follows: 95 C for 2 min, 50 C for 1 min, and 68 C for 2 min, for 30
cycles using Elongase ampliﬁcation system (Invitrogen). The PCR
product was subcloned for sequence analysis into pCRIIe vector using
T/A cloning (Invitrogen). The nucleotide sequence was determined as
described in Sambrook et al. [11]. The 3 0 region of the SPDS mRNA
was determined by using the rapid ampliﬁcation of cDNA ends
(RACE) Marathon kit (Clontech) with total C. elegans RNA as de-
scribed by the manufacturer. PCR was performed using the obtained
Marathon cDNA library of C. elegans as template and the gene-spe-
ciﬁc oligonucleotide CeSPDS-S1 5 0-GAACGAGTTCGACGTAA-3 0
(sense) and the oligo-dT-primer (antisense). The identiﬁed RACE
products were cloned into pCRIIe, sequenced and analysed.
The open reading frame of C. elegans SPDS was cloned into
pTrcHisB vector (Invitrogen) to produce a His-tag fusion protein.
The recombinant expression plasmid pTrcHisB:CeSPDS was
sequenced to ensure that the inserts were in the correct reading frame.
Subsequently, the E. coli strain BLR (DE3) was transformed with
pTrcHisB:CeSPDS.
2.4. Recombinant expression and puriﬁcation of C. elegans SPDS
A fresh overnight culture from a single colony of the E. coli expres-
sion cells containing pTrcHisB:CeSPDS was diluted 1:100 in Luria–
Bertani medium supplemented with 100 lg/ml ampicillin and grown
at 37 C until the OD600 reached 0.5. Expression was initiated with
1 mM isopropyl b-D-thiogalactoside. The cells were grown for addi-
tional 4 h at 37 C before being harvested by centrifugation at
10000 · g for 15 min at 4 C. The cell pellet was resuspended in lysis
buﬀer containing 0.1 mM phenylmethylsulfonyl ﬂuoride, soniﬁed and
centrifuged at 100000 · g for 1 h (TFT 55.38, Centricon T-1065, Kon-
tron). Recombinant C. elegans SPDS was puriﬁed from the superna-
tant by chelating chromatography on Ni–NTA agarose (Qiagen)
according to the manufacturers recommendation. Protein was dia-
lysed against 1000 volumes of buﬀer A (50 mM KH2PO4, pH 7.4, con-
taining 1 mM EDTA, 0.1 mM dithiothreitol (DTT) and 0.1 mM
phenylmethylsulfonyl ﬂuoride).
To determine the molecular weight of the C. elegans SPDS, the elu-
ate of the chelating chromatography was subjected to fast protein li-
quid chromatography on a calibrated Superdex S-200 column
(2.6 cm · 60 cm) equilibrated with buﬀer A at a ﬂow rate of 2 ml
min1. Protein concentration was determined by the method of Brad-
ford [12]. The homogeneity of the enzyme preparations were analysed
by SDS–PAGE and subsequent Coomassie blue-staining [13].
2.5. SPDS enzyme assay
Aminopropyltransferase activity was determined by measuring the
formation of radiolabelled reaction products from [14C] putrescine or
[14C] spermidine following Samejima et al. [14]. Brieﬂy, the reaction
mixture in a ﬁnal volume of 100 ll contained 50 mM potassium phos-
phate buﬀer, pH 7.0, 1.0 mM DTT, 1.0 mM EDTA, 200 lM of (S,R)-
dcAdoMet, 200 lM putrescine (50 nCi [14C] putrescine) or 200 lM
spermidine (50 nCi [14C] spermidine) and 200 ng recombinant C. ele-
gans SPDS enzyme. Following 15 min of incubation at 37 C, the reac-
tion was terminated by heating for 5 min at 95 C.Separation of the reaction product was performed by thin layer
chromatography on silica gel 60 sheets (Merck) with ethylenglycol-
monomethylether, propionic acid and H2O saturated with NaCl
(140:30:30, v/v/v) as the mobile phase [15]. 10 ll of the assay together
with 2 ll of each 50 mM polyamine standards were applied onto the
sheets and run for 4 h. Spermidine and putrescine were visualised
either by ninhydrin staining at 60 C or by autoradiography (BIO-
MAX, Kodak). Spots were cut out and radioactivity was measured
in a Packard-Tricarb 2000 liquid scintillation counter using 3 ml Pack-
ard UltimaGold? Liquid scintillation cocktail.
For the determination of Km values, concentrations of putrescine
varied from 25 to 750 lM and of S-dcAdoMet from 10 to 300 lM.
The synthetic dcAdoMet preparation that was used contains the bio-
logically active S-isomer together with the biologically inactive R-form
of dcAdoMet in a 52–48 ratio. However, it has been demonstrated pre-
viously that R-dcAdoMet does not have any eﬀect on SPDS enzyme
reaction [16]. Kinetic parameters were calculated by Lineweaver–Burk
plots using the program GRAPHPAD PRISM 1.02 (GraphPad Software,
San Diego, CA). Inhibition tests were performed in standard assays
supplemented with varying concentrations of the inhibitors cyclohexyl-
amine (1–10 lM), 4-MCHA (0.5–50 lM) and MTA (10–1000 lM).2.6. Crystallization of C. elegans SPDS
For crystallization, the recombinant C. elegans SPDS was puriﬁed as
described above with minor modiﬁcations: Tris–HCl buﬀer, pH 8.0,
was used instead of the phosphate buﬀer. Washes from the column
were done with four bed volumes of 20–250 mM imidazole in wash
buﬀer. Fractions were checked on SDS–PAGE and those containing
the least impurities (100, 150 and 250 mM) were pooled and dialysed
overnight against 20 mM Tris–HCl, pH 8.0, 1 mM DTT. The protein
was concentrated to 5 mg/ml and the molecular weight checked on na-
tive PAGE.
Before setting up crystallization drops, the protein (5 mg/ml) was
mixed with 100 lM of putrescine. Initial conditions were found using
the Index Screen (Hampton Research) by mixing equal volumes of
protein and well solutions in sitting drops at 21 C. Platelet crystals ap-
peared after one day in many conditions containing PEG 3350 and dif-
ferent salts. 25% PEG 3350, 0.2 M lithium sulphate, 0.1 M Tris–HCl
buﬀer, pH 8.0 was chosen because the crystals looked better as the
pH increased from 5.5 to 8.0. Most crystals grew together and were
twinned. Further screening for better conditions with Additive Screen
3 (Hampton Research) was done. Addition of 0.01 M DDT gave fairly
single crystals near the edges of the drop. The ﬁnal crystallization con-
dition consisted of 25% PEG 3350, 0.2 M lithium sulphate, 0.1 M Tris–
HCl, pH 8.0, 0.01 M DTT well solution and 10 ll drop (4 ll protein-
putrescine and 6 ll well solution) as increasing the drop size gave more
single crystals. The crystals diﬀracted to 2.5 A˚ at the synchrotron and
belonged to space group P21 with cell dimensions a = 59.99 A˚,
b = 99.23 A˚, c = 67.85 A˚, b = 107.20, with two molecules per asymmet-
ric unit, and solvent content of 55%.2.7. Data collection and processing
Diﬀraction data were collected at the beamline XO6SA of the Swiss
Light Source, Paul Scherrer Institut, Villigen, Switzerland. Crystals
were transferred to a drop containing a cryoprotectant consisting of
18 ll reservoir solution and 3 ll PEG 400 for a few seconds before
ﬂash freezing in liquid nitrogen stream at 100 K. Data were processed
using the XDS package [17]. Data quality was checked with program
TRUNCATE [18]. A summary of data statistics is shown in Table 1.2.8. Structure determination and reﬁnement
Initial phases were calculated by molecular replacement using the
program Phaser [19] with anisotropic correction. Two molecules per
asymmetric unit were searched for using chain C of the T. maritima
SPDS structure (pdb Accession No. 1INL). Rigid body reﬁnement
of the solution was done with Refmac5 [20]. Model bias was removed
using prime-switch in RESOLVE [21]. Successive rounds of model
building, temperature factor reﬁnement and positional reﬁnement were
done with programs O [22], CNS v 1.1 [23] and REFMAC5 [20], respec-
tively. Non-crystallographic symmetry was used in the reﬁnements.
Twenty water molecules were initially picked with Arp/wARP [24]
and the rest were subsequently built using the program O. The model
was checked with PROCHECK [25].
Table 1









No. of observed/unique reﬂections 65243/25260
Completeness (%) 94.9(88.4)
I/r(I) 9.97(2.38)
Rmrgd-F (%) 15.0 (56.6)
Molecules/asymmetric unit 2
% Solvent/VM (A˚3/Da) 55.0/2.8
Reﬁnement resolution (A˚) 20–2.5
Total no. of reﬂections 24926
Reﬂections in working set 24573
Reﬂections in test set 353
R-factor/Rfree (%) 20.9/25.7
Wilsons B-factor (A˚2) 56.4
Overall B-factor (A˚2) 50.55
Water molecules 92
Bond length RMSD (A˚) 0.016
Bond angles RMSD () 1.900





Fig. 1. SDS–PAGE analysis of the recombinant C. elegans SPDS.
Lanes 1–5 represent protein extracts from E. coli BL21(DE3) induced
with 1 mM IPTG (see Section 2). Coomassie blue-stained SDS–PAGE
(10% polyacrylamide separation gel) of the 100000 · g pellet (lane 1)
and supernatant (lane 2) of lysed cells containing pTrcHisB without
insert, of the 100000 · g pellet (lane 3) and supernatant (lane 4) of
lysed cells containing pTrcHisB:CeSPDS and of recombinant His-
tagged C. elegans SPDS puriﬁed by Ni–NTA-chelating chromatogra-
phy (lane 5). The size of the protein standard is shown in kDa on the
left.
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3.1. Characterisation of C. elegans SPDS cDNA
A 945 bp PCR fragment was ampliﬁed from C. elegans
cDNA using gene-speciﬁc oligonucleotides based on the
EMBL genomic nucleotide sequence Accession No.
AL110485. The cDNA sequence encodes an open reading
frame that shows high similarity to amino acid sequences of
known SPDS. However, the obtained nucleotide sequence
does not resemble the cDNA sequence published in the Sanger
Centre GenBank [Accession No. AL110485]. Here, an addi-
tional exon of 156 bp was proposed within intron IV. We
could not conﬁrm this result by our cDNA sequences obtained
either by PCR on reversed transcribed mRNA nor by clones
obtained from a k-Zap cDNA library. A rapid ampliﬁcation
of cDNA 3 0 ends was performed using a Marathon cDNA li-
brary of C. elegans as template. A 600 bp PCR product was
found that encompasses the entire 3 0 UTR of 56 bp including
a typical polyadenylation signal sequence (AATAAA) located
20 bp upstream of the poly (A)+ tail. Analyses of the 5 0 UTR
have been performed previously [6]. In conclusion, the C. ele-
gans SPDS cDNA consists of 1013 bp and encodes a polypep-
tide of 314 amino acids with a deduced molecular mass of
35.0 kDa.
3.2. Characterisation of the recombinant C. elegans SPDS
C. elegans SPDS was recombinantly expressed as His-tag fu-
sion proteins in E. coli. One litre of bacterial culture yielded
about 10-mg puriﬁed protein. SDS–PAGE analysis revealed
a single band with a molecular mass corresponding to
38 kDa including the His-tag of 3 kDa (Fig. 1). This is in good
accordance with the predicted molecular mass of 35.0 kDa
based on the amino acid sequence deduced from the cDNA.The molecular mass of the C. elegans protein lies in the same
range as those reported for the SPDS from mammals
(35 kDa), E. coli (36.5 kDa) and plants like N. sylvestris
(38.7 kDa) [16,26,27]. Performing gel ﬁltration on a calibrated
Superdex S-200 column resulted in a single peak corresponding
to a molecular weight of 78000 (data not shown), indicating a
dimeric structure of the enzymatically active C. elegans SPDS.
Most SPDS exhibit a homodimeric structure [1]. The T. mari-
tima SPDS, however, forms a tetramer [4].
The recombinant C. elegans enzyme has a speciﬁc activity of
1.8 lmol min1 mg1 protein resulting in a kcat of 69.2 min
1.
This is in the same range as those published for SPDS isolated
from mammalian sources (660–1300 nmol min1 mg1)
[14,28]. The Km value for putrescine was calculated to be
158 ± 27 lM (n = 5), which is comparable with the Km values
reported for mammalian enzymes (100 lM) [14,28]. Like for
mammalian SPDS [29], the C. elegans enzyme is characterised
by a high speciﬁcity towards putrescine. Hence, spermidine
could not replace putrescine as aminopropyl acceptor (data
not shown). The Km value for the second substrate dcAdoMet
was determined to be 111 ± 5 lM (n = 3), which is about 15-
fold to 100-fold higher than those reported for mammalian
SPDS [26,30]. A relatively high Km value for dcAdoMet
(35 lM) has also been reported for the Plasmodium falciparum
SPDS [4]. The enzyme reaction of C. elegans SPDS is inhibited
by the second product MTA with an IC50 of 430 lM (n = 2).
Therefore, a physiological function of feedback inhibition by
MTA seems to be unlikely in C. elegans. The mammalian
SPDS is 10 times more sensitive towards MTA. A concentra-
tion of about 30 lM MTA is needed for 50% inhibition of en-
zyme activity [31].
C. elegans SPDS activity was aﬀected by the synthetic inhib-
itors 4-MCHA and cyclohexylamine with IC50 values of
7.2 lM (n = 2) and 2.4 ± 0.7 lM (n = 4), respectively. This is
in the same range as the IC50 values that have been reported
for mammalian SPDS (8.1 lM for cyclohexylamine and
1.7 lM for 4-MCHA) [32,33]. Both compounds are known
competitive inhibitors with respect to putrescine [1,33].
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lian counterparts to a great extent. However, the low aﬃnity
for dcAdoMet and the feedback inhibitor MTA are speciﬁc
for C. elegans SPDS.
3.3. Three-dimensional structure and dimeric organisation of C.
elegans SPDS
The X-ray crystallographic structure of the C. elegans SPDS
enzyme shows a homodimer (Fig. 2), which is in accordance
with biochemical data presented above. Each subunit consists
of two domains: A six-stranded b-sheet builds up the structural
framework of the N-terminal domain (residues 3–92) and a
Rossman-fold like unit builds up the C-terminal domain (res-
idues 93–314). A total of 26 residues at the N-terminus (resi-
dues 1–2 and 18–40) and fourteen residues at the C-terminus
(residues 190–202) could not be modelled due to weak electron
density. Although the crystallisation was attempted in complex
with one of the substrates, putrescine, no electron density for it
was detected in the active site, which may suggest that the
presence of both substrates is a prerequisite for their stable
binding. This function could be regulated by the nematode-
speciﬁc insertion, the possible structural role of which is
discussed below.
Non-crystallographic symmetry restraints were imposed on
the dimer during reﬁnement, thus the two independent sub-
units are identical with the RMSD between the Ca atoms
being 0.08 A˚. Subunit interaction was analysed using the
Protein–Protein Interactions Server (http://www.biochem.
ucl.ac.uk/bsm/PP/server). The dimer interface is formed by
packing interactions between residues from helices and strands
(a1, a6, a7, a8, a9, b1, b2, b3, b11, b12, b13), and the loops
between strands and helices (b2–b3, b3–b4, b6–a1, b11–a6,
b12–b13, a7–a8, a8–a9), of each subunit. The interface buries
around 1660 A˚2 of the total accessible surface area of each
monomer. A total of 95 residues from both subunits, of which
64 are non-polar, contribute to surface interactions. There are
thirteen hydrogen bonds and six bridging waters. Most of theFig. 2. A schematic view of the dimer of C. elegans SPDS. The N-
terminal domain (residues 3–92) of each monomer is coloured in cyan
and the C-terminal domain (residues 93–314) in brown. The AdoMet
molecule modelled from the human SPDS is shown in sticks to mark
the location of the active site. The positions of the N- and C-termini
are marked. Figure was prepared using PYMOL [35], http://
pymol.sourceforge.net/.hydrogen bonds are formed through main chain atoms. Two
hydrogen bonds (one/subunit) involve the side chains of Y74
and Q49, and two hydrogen bonds involve the side chain of
T73 and the main chain of P44.
In contrast to the dimeric organisation of the C. elegans
SPDS, the three-dimensional structure of T. maritima SPDS
is a homotetramer, which is probably better described as a di-
mer of dimers. The subunits within each of the dimers are
organised in a fashion which resembles domain organisation
in C. elegans SPDS. The interface between the subunits within
a dimer buries around 1894 A˚2 of the accessible surface area of
each monomer, compared to 1660 A˚2 in C. elegans SPDS.
There are 22 H-bonds at the interface compared to thirteen in
CeSPDS. The T. maritima SPDS tetramer is stabilised by a
tight b-barrel with a hydrophobic core formed by four N-termi-
nal hairpins (built up by strands b1 and b2). The same hairpin is
also present in C. elegans SPDS. However, a comparison of the
amino acid sequences of T. maritima and C. elegans enzymes
shows that this region is not well conserved, especially between
bacterial and eukaryotic sequences (Fig. 3A). These diﬀerences
may prevent the formation of the barrel structure by the C. ele-
gans enzyme. There are also 12 additional residues at the N-ter-
minus of T. maritima SPDS, when compared to the C. elegans
enzyme. These residues contribute additional interactions be-
tween the subunits, which may enhance the stability of the tet-
ramer. Probably one should also take into account the
nematode-speciﬁc loop, which in the C. elegans SPDS structure
is located between strands b1 and b2 (Figs. 3B and 4). This loop
may also aﬀect the stability of the hairpin formed by b1 and b2
and may interfere with the formation of a tetramer.
3.4. Comparison with other SPDS structures
Pairwise sequence alignment using BCM search launcher
(http://searchlauncher.bcm.tmc.edu/) reveals that the amino
acid sequence of C. elegans SPDS is very similar to the coun-
terpart of the human-parasitic nematode Brugia malayi
[unpublished] (55%) and also to other known SPDS with se-
quence identities of 57% to the human [27], 48% to the Nicoti-
ana sylvestris [34], 41% to the E. coli [35] and 43% to the T.
maritima [4] proteins (Fig. 3A).
The structure of T. maritima and human SPDS were deter-
mined in complex with the inhibitor AdoDATO and with Ado-
Met, respectively. The structures demonstrate a high level of
conservation of the overall topology (Fig. 4). Thus, the struc-
tures of T. maritima and human SPDS could be superimposed
on the C. elegans enzyme with rmsd (root-mean square devia-
tion) for the Ca-atoms of around 1 A˚. The largest diﬀerences
between the C. elegans and T. maritima enzymes are found
in the region of helices a3, a4 and a6 (residues 142–151,
168–177 and 230–242, respectively; C. elegans numbering).
There are shifts in the Ca atom positions of up to 3 A˚ in this
region. A superposition of the structures of human and T.
maritima SPDS shows that the diﬀerences are maintained for
helices a3 and a6, while helix a4 superimposes well on the cor-
responding helix from the T. maritima enzyme. Although the
structure of a ligand-free human enzyme is not available, a
comparison between the apo- and inhibitor complex structures
of T. maritima SPDS does not show any diﬀerences in the po-
sition of this helix. Taking into account that a4 builds up part
of the substrate binding cleft, the diﬀerence between the human
and C. elegans enzymes may be of interest for future design of
nematode-speciﬁc inhibitors.
Fig. 3. Alignment of SPDS amino acid sequences (A). The amino acid sequence of C. elegans SPDS is compared with the B. malayi, the human
[EMBL Accession No. AAA36633], the N. sylvestris [EMBL Accession No. BAA24535], the E. coli [EMBL Accession No. P09158] and the T.
maritima SPDS. Amino acid residues that are invariant in at least four additional sequences are shaded in black, similar amino acids in grey. The N-
terminus of the human, the N. sylvestris and the T. maritima sequence is omitted as indicated. Gaps () are introduced to provide maximum
similarity. The position of the secondary structure elements is shown along the sequence. (B) The nematode-speciﬁc insertion of C. elegans SPDS is
aligned with the respective regions of putative SPDS from the nematodes C. briggsae [www.genome.wustl.edu/gsc/Projects/C.briggsae/], Ancylostoma
caninum [EMBL Accession No. AW626946], Haemonchus contortus [EMBL Accession No. BF060177], Ascaris suum [EMBL Accession No.
BI783107] Meloidogyne hapla [EMBL Accession No. BM883048] and B. malayi. The N-terminus of the H. contortus sequence is unknown. The
respective region of the human SPDS is aligned to indicate the insertion. Identical amino acid residues are shaded in black, similar in grey. Gaps ()
are introduced to provide maximum similarity.
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DATO shows that the putrescine-binding site is a hydrophobic
cavity, which includes two negatively charged sites responsible
for anchoring the amino groups of the molecule. In particular,
Asp170 (T. maritima numbering) has been proposed to be
responsible for deprotonating the attacking amino group ofputrescine, whereas Tyr76 and Ser171 are thought to be in-
volved in binding and proper orientation of the diamine. The
corresponding residues in the C. elegans enzyme are Tyr94,
Asp188 and Ser189. In total, 20 amino acid residues are in-
volved in interactions with the inhibitor. Of these 16 are con-
served, whereas four have been exchanged in C. elegans
Fig. 4. A superposition of the structures of T. maritima (brown) and C. elegans SPDS. The gatekeeper loop in the T. maritima enzyme is shown in
yellow. The few nematode-speciﬁc insert residues that could be modelled are shown in red sticks. The positions of the N- and C-termini in both
proteins are marked.
6042 V.T. Dufe et al. / FEBS Letters 579 (2005) 6037–6043(Met67 to Gln85, His77 to Gln95, Gln178 to Pro195 and
Trp244 to Met261). Fig. 5 shows the overall topology of the
substrate binding site of C. elegans SPDS. A superpositionFig. 5. Surface representation of the active site of SPDS. (A) A stereo
view showing the active site of C. elegans SPDS. Side chains of residues
that have diﬀerent conformations in T. maritima (blue sticks) and C.
elegans SPDS are shown. Also shown is the inhibitor AdoDATO in the
position found in the complex with the T. maritima enzyme. The
residue numbers/names in brackets are for T. maritima SPDS. (B) A
stereo view showing the active site of C. elegans SPDS. Side chains of
residue that have diﬀerent conformations in human (green sticks) and
C. elegans SPDS are shown. There is only one substitution; I246 of the
human enzyme is M261 in C. elegans. Also shown is AdoMet in the
position found in the complex with human SPDS. The residue
numbers/names in brackets are for the human SPDS.on the structure of the T. maritima enzyme (Fig. 5A) shows
that the position and conformation of some side chain and
main chain atoms (Tyr94, Asp170, Phe172, Tyr256, Gln221,
and Met261) is diﬀerent. Some of these diﬀerences are due to
the shifts in the position of helices a4 and a6, as described
above. It should also be noted that the superposition of the
T. maritima apo- and inhibitor-bound structures shows no dif-
ferences in side-chain conformations within the active site cleft.
Thus, the observed diﬀerences between the C. elegans and T.
maritima SPDS may not depend on the absence of bound sub-
strate in the C. elegans enzyme. The active site clefts of the hu-
man and C. elegans SPDS is much more conserved, with only
few diﬀerences in amino acid position (Fig. 5B).
Another feature of the active site of SPDS is a loop region,
described by Korolev et al. [4], who proposed it to function as
a gatekeeper to or from the binding pocket of the T. maritima
enzyme. In the three-dimensional structure this region is lo-
cated between strand b10 and helix a5 (Figs. 3A and 4). Six
of these amino acid residues are conserved in the nematode se-
quence 189-SSDPVGPAE-197. Moreover, an amino acid resi-
due corresponding to Thr175 of the T. maritima loop is lacking
in the C. elegans and all other SPDS. Unfortunately in the pre-
sented three-dimensional structure from C. elegans the region
of the gatekeeper loop is disordered, most probably due to
the lack of substrate in the active site. Also in the apo-structure
of T. maritima SPDS this region is disordered.
The nematode-speciﬁc insertion mentioned above contains
27 amino acids and is located close to the N-terminus (Figs.
3B and 4). The amino acid sequence of the insertion reﬂects
the phylogenetic relationship of the nematodes according to
the taxonomic classiﬁcation by Blaxter et al. [34]. Caenorhab-
ditis briggsae, Ancylostoma caninum, Ascaris suum and Hae-
monchus contortus are members of the same clades as C.
elegans and the identity of their SPDS insertions, with respect
to the C. elegans sequence, is 74–62%. The value for Meloido-
gyne hapla is 30% and B. malayi with a value of 11% (3 iden-
tical amino acids in 27) exhibits the greatest phylogenetic
distance to C. elegans. In the three-dimensional structure the
region corresponding to the nematode-speciﬁc sequence is
unfortunately disordered. However, it is clear that this loop,
which represents a unique structural feature of nematode
SPDS, is located in close proximity to the putative gatekeeper
V.T. Dufe et al. / FEBS Letters 579 (2005) 6037–6043 6043loop (Fig. 4). This location may indicate an interaction be-
tween these two regions of the molecule in the regulation of
the function of the enzyme. However, the contribution of this
interaction has to be elucidated in further studies.
Another feature of C. elegans SPDS is a coiled region be-
tween Ala 278 and Thr282, which in the T. maritima structures
is a short helix (Pro262–Phe267). Curiously, in the adjacent re-
gion a coil between Arg265 and Glu270 (T. maritima number-
ing) is substituted by a helix in C. elegans. This diﬀerence is
speciﬁc for the T. maritima enzyme, since in the human SPDS
the structure in this region is similar to that from C. elegans.
The coordinates have been deposited in the Protein Data Bank
with Accession No. 2B2C.
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